Your browser doesn't support javascript.
loading
Daratumumab, lenalidomide, and dexamethasone versus lenalidomide and dexamethasone alone in newly diagnosed multiple myeloma (MAIA): overall survival results from a randomised, open-label, phase 3 trial.
Facon, Thierry; Kumar, Shaji K; Plesner, Torben; Orlowski, Robert Z; Moreau, Philippe; Bahlis, Nizar; Basu, Supratik; Nahi, Hareth; Hulin, Cyrille; Quach, Hang; Goldschmidt, Hartmut; O'Dwyer, Michael; Perrot, Aurore; Venner, Christopher P; Weisel, Katja; Mace, Joseph R; Raje, Noopur; Tiab, Mourad; Macro, Margaret; Frenzel, Laurent; Leleu, Xavier; Ahmadi, Tahamtan; Wang, Jianping; Van Rampelbergh, Rian; Uhlar, Clarissa M; Tromp, Brenda; Delioukina, Maria; Vermeulen, Jessica; Usmani, Saad Z.
Afiliación
  • Facon T; University of Lille, Centre Hospitalier Universitaire de Lille, Service des Maladies du Sang, Lille, France. Electronic address: thierry.facon@chru-lille.fr.
  • Kumar SK; Department of Hematology, Mayo Clinic Rochester, Rochester, MN, USA.
  • Plesner T; Vejle Hospital and University of Southern Denmark, Vejle, Denmark.
  • Orlowski RZ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Moreau P; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.
  • Bahlis N; Arnie Charbonneau Cancer Research Institute, University of Calgary, Calgary, AB, Canada.
  • Basu S; The Royal Wolverhampton NHS Trust and University of Wolverhampton, Wolverhampton, UK.
  • Nahi H; Karolinska Institute, Department of Medicine, Division of Hematology, Karolinska University Hospital at Huddinge, Stockholm, Sweden.
  • Hulin C; Department of Hematology, Hôpital Haut Lévêque, University Hospital, Pessac, France.
  • Quach H; University of Melbourne, St Vincent's Hospital, Melbourne, VIC, Australia.
  • Goldschmidt H; University Hospital Heidelberg, Internal Medicine V and National Center for Tumor Diseases, Heidelberg, Germany.
  • O'Dwyer M; Department of Medicine/Haematology, National University of Ireland, Galway, Ireland.
  • Perrot A; Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse - Oncopole, Université de Toulouse, Université Paul Sabatier, Service d'Hématologie, Toulouse, France.
  • Venner CP; Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada.
  • Weisel K; Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Mace JR; Florida Cancer Specialists, St Petersburg, FL, USA.
  • Raje N; Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • Tiab M; Centre Hospitalier Départemental Vendée, La Roche sur Yon, France.
  • Macro M; Centre Hospitalier Universitaire de Caen, Caen, France.
  • Frenzel L; Department of Clinical Haematology, Hopital Necker-Enfants Malades, Paris, France.
  • Leleu X; Centre Hospitalier Universitaire de Poitiers, Hôpital la Milétrie, Poitiers, France.
  • Ahmadi T; Genmab US, Plainsboro, NJ, USA.
  • Wang J; Janssen Research & Development, Raritan, NJ, USA.
  • Van Rampelbergh R; Janssen Research & Development, Beerse, Belgium.
  • Uhlar CM; Janssen Research & Development, Spring House, PA, USA.
  • Tromp B; Janssen Research & Development, Leiden, Netherlands.
  • Delioukina M; Janssen Research & Development, Spring House, PA, USA.
  • Vermeulen J; Janssen Research & Development, Leiden, Netherlands.
  • Usmani SZ; Levine Cancer Institute/Atrium Health, Charlotte, NC, USA.
Lancet Oncol ; 22(11): 1582-1596, 2021 11.
Article en En | MEDLINE | ID: mdl-34655533
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Lenalidomida / Anticuerpos Monoclonales / Mieloma Múltiple Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Dexametasona / Protocolos de Quimioterapia Combinada Antineoplásica / Lenalidomida / Anticuerpos Monoclonales / Mieloma Múltiple Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Aged / Female / Humans / Male Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article